NEW YORK (GenomeWeb) – Caris Life Sciences filed a patent infringement lawsuit against Foundation Medicine yesterday in the US District Court for the District of Massachusetts Boston Division.
The Irving, Texas-based company claims that three of Foundation Medicine's cancer genomic profiling tests — FoundationOne for solid tumors, FoundationOne Heme for hematological tumors and sarcomas, and the liquid biopsy test FoundationAct — infringe five of its US patents.